A mixed methods study of recruitment in PrecISE

Overview

About this study

The purpose of this study is to identify the reasons for deferred randomization and trial participation based on demographic factors, including sex, age, race, and ethnicity with a mixed methods study. We will employ an exploratory quantitative study of PreCISE network data examining those who were screened but did not undergo randomization. We will explore data including a review of reasons for deferred randomization and trial participation and demographics, including sex, age, race, and ethnicity, compared to volunteers who underwent screening and randomization (N=358). Demographic data reviewed will include individuals who were ineligible due to incomplete data (N=187) and those who refused to join (N=106). We will also conduct semi structured, qualitative interviews utilizing grounded theory methodology including site PIs and CRCs to determine 1) factors that facilitated study enrollment and 2) barriers to enrollment. One representative from each of the 33 PrecISE sites will be invited to participate in a semi structured, qualitative interview lasting no more than 30 minutes. Study staff include either site PIs or CRCs who were involved in PrecISE recruitment efforts.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclsuion Criteria: 

  •  ≥ 18 years of age. 

Exclusion Criteria:

  • Less than 18 years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/24/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Ann Rusk, M.D.

Contact us for the latest status

Contact information:

Clinical Studies Unit

(904) 953-2255

More information

Publications

Publications are currently not available
.
CLS-20584626

Mayo Clinic Footer